| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.042 | 0.5 |